← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2009Last known activity
Sep 12, 2025
Timeline
2000s
- Jan 1, 2006
National Institute for Health Research, United Kingdom— Founded
Drugs by trial phase (149 distinct, 115 trials)
Phase 4 (46 own, 0 via acquisition)
Phase 3 (29 own, 0 via acquisition)
Phase 2 (51 own, 0 via acquisition)
Phase 1 (13 own, 0 via acquisition)
Other trials (10 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Adrenal Insufficiency
- Anemia
- Aneurysm
- Anxiety Disorders
- Aortic Aneurysm
- Aortic Aneurysm, Abdominal
- Arthritis, Psoriatic
- Asthma
- Barrett Esophagus
- Brain Diseases
- Brain Ischemia
- Breast Neoplasms
- Carcinoma
- Carcinoma, Neuroendocrine
- Carcinoma, Non-Small-Cell Lung
- Cardiovascular Diseases
- Cerebral Hemorrhage
- Cholangitis
- Cholangitis, Sclerosing
- Clostridium Infections
- Colorectal Neoplasms
- Communicable Diseases
- Coronavirus Infections
- Critical Illness
- Crohn Disease
- Cystadenocarcinoma, Serous
- Depression
- Depressive Disorder
- Dermatitis
- Dermatitis, Atopic
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Diabetic Retinopathy
- Diarrhea
- Eczema
- Embolism
- Encephalitis
- Epilepsy
- Familial Primary Pulmonary Hypertension
- Fatigue
- Fatty Liver
- Fibrosis
- Flushing
- Gout
- Head and Neck Neoplasms
- Heart Failure
- Hemorrhage
- Hepatitis
- Hepatitis A
- Hepatitis C
- HIV Infections
- Hot Flashes
- Hyperprolactinemia
- Hypertension
- Hypothyroidism
- Hypoxia
- Infarction
- Infections
- Inflammation
- Insulin Resistance
- Irritable Bowel Syndrome
- Kidney Diseases
- Kidney Failure, Chronic
- Liver Cirrhosis
- Liver Cirrhosis, Biliary
- Liver Diseases
- Lung Diseases
- Lung Diseases, Obstructive
- Lung Neoplasms
- Lupus Erythematosus, Cutaneous
- Lupus Erythematosus, Discoid
- Lupus Erythematosus, Systemic
- Malaria
- Malaria, Falciparum
- Melanoma
- Multiple Sclerosis
- Multiple Sclerosis, Chronic Progressive
- Myocardial Infarction
- Myocardial Reperfusion Injury
- Neoplasm Metastasis
- Neoplasms
- Non-alcoholic Fatty Liver Disease
- Osteoporosis
- Osteosarcoma
- Pancreatitis
- Peritonitis
- Pneumonia
- Postoperative Pain
- Premature Birth
- Pulmonary Disease, Chronic Obstructive
- Pulmonary Embolism
- Renal Insufficiency, Chronic
- Reperfusion Injury
- Retinal Diseases
- Sclerosis
- Sepsis
- Severe Acute Respiratory Syndrome
- Stroke
Recent trials (50)
- NCT07207057CollaboratorPhase 3Sep 12, 2025
- NCT05772013CollaboratorPhase 4May 31, 2023
- NCT05405868CollaboratorPhase 3Mar 31, 2023
- NCT05085028CollaboratorPhase 3Jun 1, 2022
- NCT05299242CollaboratorPhase 2/Phase 3May 27, 2022
- NCT05093231CollaboratorPhase 2Mar 3, 2022
- NCT04678869CollaboratorN/ADec 1, 2021
- NCT04941911CollaboratorPhase 2Jul 1, 2021
- NCT04852367CollaboratorPhase 1Jun 16, 2021
- NCT05434195CollaboratorN/AJun 1, 2021
- NCT05627154CollaboratorN/AMay 28, 2021
- NCT05026398CollaboratorPhase 4Apr 12, 2021
- NCT04671017CollaboratorPhase 1/Phase 2Dec 16, 2020
- NCT04706429CollaboratorPhase 2Dec 1, 2020
- NCT04648033CollaboratorPhase 1Nov 30, 2020
Details
- Founded
- London, GB Jan 1, 2006
- Last known activity
- Sep 12, 2025